Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: An open-label study

by Kim J.-M., Chung S.J., Kim J.W., Jeon B.S., Singh P., Thierfelder S., Ikeda J., Bauer L., Sohn Y.-H., Lee M.S., Kim S.J., Cho J.W., Kim H.T., Park K.W., Lee H.-W., Irene L., Abd Aziz Z.B., Sim S.H., Tsai C.-H., Zheng T.-J., Wu R.-M., Schwartz R., Beran R., Evans A., Hayes M., Tan L., Tan E.K.
Published 2018